NCT07562152 · Interventional trial
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Overall registry status Recruiting
Phase 3
Conditions PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic, Pancreatic Cancer, Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC)
Delaware Valley sites
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory